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CHANGES  IN  APOPTOTIC  ACTIVITY  DRIVEN  BY  DNA  
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Apoptosis is one of the fundamental biological phenomena, well known to be 
crucial in cancer development for its vital role in a subtle interplay between prolif-
eration and cell death. Programmed cell death is indeed a powerful physiological 
frontier cancer cells have to overcome along the way of fulfilling their full malig-
nant potential. Therefore, complex signalling networks developed in the frame of 
apoptosis which can be crashed not only by gene mutations but disruption in gene 
expression regulation as well. DNA methylation is one of the most prominent epi-
genetic mechanisms strongly effecting gene expression by organizing chromatin 
status and its permissiveness to transcription. Aberrant DNA methylation is an epi-
mutation already recognized as an early event, sometimes even preceding other 
well-known molecular carcinogenic incidences.  Reports from literature, which will 
be discussed in this lecture, point to DNA methylation epimutations as underlying 
mechanism of aberrant apoptotic gene expression resulting in a breach of cell ho-
meostasis regulatory mechanisms toward carcinogenesis.
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Programmed cell death, or apoptosis, is a fundamental mechanism of tissue 
homeostasis. In the normal colon, as much as 10^10 cells per day undergo apoptosis 
and are shed into the lumen. One of the hallmarks of cancer is escape from mecha-
nisms regulating apoptosis, such as cellular response to extrinsic growth factors 
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and telomere shortening. Escape from apoptosis also makes cancer cells resistant to 
chemotherapy and radiation. The molecular machinery of apoptosis is a potential 
target for drugs that could promote cell death in colorectal cancer cells. The intrin-
sic (mitochondrial) pathway of apoptosis is regulated mainly the the Bcl-2 protein 
family, which are activated by various stimuli, including growth factor withdrawal 
and cellular damage. Under such circumstances, the antiapoptotic factors (eg. Bcl-2, 
Bcl-XL, Bcl-W, Mcl-1) release the proapoptotic factors (eg. BAK, BAX), which in turn 
increase mitochondrial membrane permeability, leading to cytochrome C release 
and Caspase 9 activation and consequently, via Caspase 3 activation, to apoptosis. 
In cancer antiapoptotic Bcl-2 family members are overexpressed, while the proap-
optotic factors are underexpressed. “BH-3 mimetics” are a class of small molecules 
inhibitors of certain antiapoptotic Bcl-2 family members. Navitoclax is a potent in-
hibitor of Bcl-2, Bcl-W and Bcl-XL, with in vitro evidence of apoptosis induction in 
colorectal cancer cells, and demonstrated safety in a phase I clinical trial in combina-
tion with established therapy regimes. Obatoclax is a promising pan-Bcl-2 inhibitor. 
HA14-1 is a small molecule selectively targeting Bcl-2. Oblimersen is an antisense 
oligonucleotide targeting Bcl-2, and has shown safety in phase I trials. In summary, 
several new drugs focusing on apoptosis induction in colorectal cancer are current-
ly being studied, which will hopefully lead to better therapies in the future.
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Emperipolesis means active penetration of one cell by another which remains 
intact. Main cells participating in emperipolesis usually are histiocytes, but other 
cell types may participate. Emperipolesis can also be found in some cancers. 
The exact mechanism for emperipolesis is not fully known but it is believed that 
the pathway of lizosom degradation mediated NK (“natural killer”) cells is crucial 
in this process. It was noted that NK cells use emperipolesis when leading tumor 
cells to programmed cell death. Process similar to emperipolesis, called entosis was 
also described, but with the different ultrastructural pathways and molecules in-
